{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:41:28Z","timestamp":1777470088437,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2016,12,2]]},"DOI":"10.3233\/bd-160237","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T10:21:49Z","timestamp":1476440509000},"page":"133-141","source":"Crossref","is-referenced-by-count":7,"title":["Breast cancer brain metastases: Molecular subtype, treatment and survival"],"prefix":"10.1177","volume":"36","author":[{"given":"Jennifer A.","family":"Crozier","sequence":"first","affiliation":[{"name":", Mayo Clinic, , , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren F.","family":"Cornell","sequence":"additional","affiliation":[{"name":", Mayo Clinic, , , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupendra","family":"Rawal","sequence":"additional","affiliation":[{"name":", Mayo Clinic, , ,\u00a0USA"},{"name":", Dana Farber Cancer Institute, , , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith A.","family":"Perez","sequence":"additional","affiliation":[{"name":", Mayo Clinic, , , USA"},{"name":", , , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/BD-160237_ref1","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"key":"10.3233\/BD-160237_ref2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12282-010-0207-8","article-title":"Radiation therapy for brain metastases in breast cancer patients","volume":"18","author":"Aoyama","year":"2011","journal-title":"Breast Cancer"},{"key":"10.3233\/BD-160237_ref3","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy versus stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.3233\/BD-160237_ref4","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/cncr.11436","article-title":"Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma","volume":"97","author":"Bendell","year":"2003","journal-title":"Cancer"},{"key":"10.3233\/BD-160237_ref5","volume-title":"2015 ASCO Annual Meeting","author":"Brown","year":"2015"},{"key":"10.3233\/BD-160237_ref6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/annonc\/mdi371","article-title":"Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy","volume":"16","author":"Burstein","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3233\/BD-160237_ref7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.3233\/BD-160237_ref8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nrclinonc.2010.119","article-title":"Whole-brain radiation therapy in breast cancer patients with brain metastases","volume":"7","author":"Chargari","year":"2010","journal-title":"Nature Rev Clin Oncol"},{"key":"10.3233\/BD-160237_ref9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00066-004-1299-x","article-title":"Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery","volume":"180","author":"Combs","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.3233\/BD-160237_ref10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00066-011-2228-4","article-title":"Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis","volume":"187","author":"D\u2019Agostino","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.3233\/BD-160237_ref11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000331196","article-title":"Combined role of whole-brain radiation therapy and radiosurgery for the treatment of brain metastasis","volume":"25","author":"Den","year":"2012","journal-title":"Prog Neurol Surg"},{"key":"10.3233\/BD-160237_ref12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D","article-title":"The natural history of breast cancer patients with brain metastases","volume":"44","author":"DiStefano","year":"1979","journal-title":"Cancer"},{"key":"10.3233\/BD-160237_ref13","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1200\/JCO.2006.07.0250","article-title":"Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer","volume":"24","author":"Gabos","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3233\/BD-160237_ref14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","article-title":"Brain metastases: epidemiology and pathophysiology","volume":"75","author":"Gavrilovic","year":"2005","journal-title":"J Neurooncol"},{"key":"10.3233\/BD-160237_ref15","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/j.ijrobp.2011.02.016","article-title":"Comparison of clinical outcomes of surgery followed by local brain radiotherapy and surgery followed by whole brain radiotherapy in patients with single brain metastasis: single-center retrospective analysis","volume":"81","author":"Hashimoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/annonc\/mdn283","article-title":"Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and\/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer","volume":"19","author":"Hines","year":"2008","journal-title":"Ann Oncol"},{"key":"10.3233\/BD-160237_ref17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02841860701558765","article-title":"Outcome of whole-brain irradiation for breast cancer patients","volume":"47","author":"Johansen","year":"2008","journal-title":"Acta Oncol"},{"key":"10.3233\/BD-160237_ref18","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky","year":"1949"},{"key":"10.3233\/BD-160237_ref19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ijrobp.2008.12.031","article-title":"Gamma Knife radiosurgery for brain metastases from primary breast cancer","volume":"75","author":"Kased","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref20","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1200\/JCO.2005.05.249","article-title":"Survival after brain metastases from breast cancer in the trastuzumab era","volume":"23","author":"Kirsch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3233\/BD-160237_ref21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jjco\/hyu126","article-title":"Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype","volume":"44","author":"Kuba","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.3233\/BD-160237_ref22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0360-3016(98)00442-8","article-title":"Identification of prognostic factors in patients with brain metastases: a review of 1292 patients","volume":"43","author":"Lagerwaard","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","article-title":"Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations","volume":"129","author":"Lee","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-160237_ref24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-007-9806-2","article-title":"Brain metastases in breast cancer: prognostic factors and management","volume":"111","author":"Lee","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-160237_ref25","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3233\/BD-160237_ref26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3816\/CBC.2003.n.016","article-title":"Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival","volume":"4","author":"Lower","year":"2003","journal-title":"Clin Breast Cancer"},{"key":"10.3233\/BD-160237_ref27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02967-X","article-title":"Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study","volume":"54","author":"Mahmoud-Ahmed","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11060-008-9578-5","article-title":"Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival","volume":"88","author":"Melisko","year":"2008","journal-title":"J Neurooncol"},{"key":"10.3233\/BD-160237_ref29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdg300","article-title":"Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival","volume":"14","author":"Miller","year":"2003","journal-title":"Ann Oncol"},{"key":"10.3233\/BD-160237_ref30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-007-9469-1","article-title":"Treatment and prognosis of brain metastases from breast cancer","volume":"86","author":"Ogawa","year":"2008","journal-title":"J Neurooncol"},{"key":"10.3233\/BD-160237_ref31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.3233\/BD-160237_ref32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00280-008-0779-6","article-title":"Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?","volume":"63","author":"Park","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.3233\/BD-160237_ref33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.bjc.6604941","article-title":"Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients","volume":"100","author":"Park","year":"2009","journal-title":"Br J Cancer"},{"key":"10.3233\/BD-160237_ref34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.3233\/BD-160237_ref35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00066-012-0093-4","article-title":"Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery?","volume":"188","author":"Rades","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.3233\/BD-160237_ref36","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.2013.54.0955","article-title":"Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Ramakrishna","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.3233\/BD-160237_ref37","doi-asserted-by":"crossref","first-page":"e85448","DOI":"10.1371\/journal.pone.0085448","article-title":"Integrated genomic and epigenomic analysis of breast cancer brain metastasis","volume":"9","author":"Salhia","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/BD-160237_ref38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","article-title":"Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients","volume":"77","author":"Sperduto","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref40","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","article-title":"Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases","volume":"82","author":"Sperduto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3233\/BD-160237_ref41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.critrevonc.2008.04.004","article-title":"Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome?","volume":"68","author":"Tosoni","year":"2008","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-160237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:38:15Z","timestamp":1777383495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-160237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":41,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/bd-160237","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}